Showing results (801-810 of 1,013) with videos related to
Sort By:
Pageof 102
Cell|March 10, 2021
A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulenceXianwen Zhang, Yang Liu, Jianying Liu, et al.Nature Immunology|June 9, 2016
Human memory T cells with a naive phenotype accumulate with aging and respond to persistent virusesVesna Pulko, John S Davies, Carmine Martinez, et al.Nature|January 7, 2026
ipRGC properties prevent light from shifting the SCN clock during daytimeRuchi Komal, Corinne Beier, Amurta Nath, et al.Biorxiv : the Preprint Server for Biology|February 3, 2021
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaquesAhmed O Hassan, Friederike Feldmann, Haiyan Zhao, et al.Cell Reports|October 16, 2021
Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBDJohn M Errico, Haiyan Zhao, Rita E Chen, et al.Cell Reports. Medicine|March 23, 2021
A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaquesAhmed O Hassan, Friederike Feldmann, Haiyan Zhao, et al.Antiviral Research|March 26, 2019
GloPID-R report on Chikungunya, O'nyong-nyong and Mayaro virus, part I: Biological diagnosticsL Pezzi, C B Reusken, S C Weaver, et al.Nature Communications|February 17, 2026
Long-acting interleukin-7 improves the efficacy of oncolytic viral therapy in glioblastomaYuping Derek Li, David A Giles, Yi Huang, et al.The Journal of Clinical Investigation|February 28, 2017
Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effectsElena Bekerman, Gregory Neveu, Ana Shulla, et al.Biorxiv : the Preprint Server for Biology|June 9, 2022
Potent and pan-neutralization of SARS-CoV-2 variants of concern by DARPinsVikas Chonira, Young Do Kwon, Jason Gorman, et al.Pageof 102